Fricke A, Ullrich P V, Cimniak A F V, Becherer C, Follo M, Heinz J, Scholber J, Herget G W, Hauschild O, Wittel U A, Stark G B, Bannasch H, Braig D, Eisenhardt S U
Department of Plastic and Hand Surgery, Medical Center - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany.
Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany.
BMC Cancer. 2017 Aug 7;17(1):527. doi: 10.1186/s12885-017-3515-y.
Microvesicles are small vesicles expressing specific antigens from their cells of origin. Elevated levels of microvesicles have been shown to be associated with coagulation disorders as well as with different types of malignancies. This study aims to evaluate a possible correlation of different microvesicle subpopulations with a positive history of venous thromboembolism (VTE) in patients with soft tissue sarcoma.
Annexin V - positive microvesicles, leukocyte (CD45-positive), platelet (CD61-positive), activated platelet (CD62P-, CD63-positive), endothelium-derived (CD62E-positive) and tissue-factor (CD142-positive) microvesicles were identified in the peripheral blood of patients with soft tissue sarcoma (n = 39) and healthy controls (n = 17) using fluorescence-activated cell sorting (FACS).
Both the total amount of Annexin V-positive microvesicles and levels of endothelium-derived (CD62E-positive) microvesicles were shown to decrease significantly after tumor resection (n = 18, p = 0.0395 and p = 0.0109, respectively). Furthermore, the total amount of Annexin V - positive microvesicles as well as leukocyte (CD45-positive) and endothelium-derived (CD62E-positive) microvesicles were significantly higher in patients with grade 3 (G3) soft tissue sarcoma (n = 9) compared to healthy controls (n = 17) (p = 0.0304, p = 0.0254 and p = 0.0357, respectively). Moreover, patients with G3 soft tissue sarcoma (n = 9) presented higher levels of Annexin V-positive and endothelium-derived (CD62E-positive) microvesicles compared to patients with grade 2 (G2) soft tissue sarcoma (n = 8) (p = 0.0483 and p = 0.0045). Patients with grade 1 (G1) soft tissue sarcoma (n = 3) presented with significantly lower levels of platelet (CD61-positive) microvesicles than patients with G3 soft tissue sarcoma (n = 9) (p = 0.0150). In patients with a positive history of VTE (n = 11), significantly higher levels of activated platelet (CD62P- and CD63-positive) microvesicles (p = 0.0078 and p = 0.0450, respectively) were found compared to patients without a history of VTE (n = 28).
We found significantly higher levels of Annexin V-positive and endothelium-derived (CD62E-positive) microvesicles to be circulating in the peripheral blood of patients with G3 soft tissue sarcoma compared to patients with G2 soft tissue sarcoma. Furthermore, we showed that high counts of activated platelet-derived microvesicles correlate with the occurrence of VTE. Thus, the detection of these microvesicles might be an interesting new tool for early diagnosis of soft tissue sarcoma patients with increased risk for VTE, possibly facilitating VTE prevention by earlier use of thromboprophylaxis.
微泡是表达其起源细胞特异性抗原的小泡。已显示微泡水平升高与凝血障碍以及不同类型的恶性肿瘤有关。本研究旨在评估软组织肉瘤患者中不同微泡亚群与静脉血栓栓塞(VTE)阳性病史之间的可能相关性。
使用荧光激活细胞分选(FACS)在软组织肉瘤患者(n = 39)和健康对照者(n = 17)的外周血中鉴定膜联蛋白V阳性微泡、白细胞(CD45阳性)、血小板(CD61阳性)、活化血小板(CD62P - 、CD63阳性)、内皮来源(CD62E阳性)和组织因子(CD142阳性)微泡。
肿瘤切除后,膜联蛋白V阳性微泡的总量以及内皮来源(CD62E阳性)微泡的水平均显著降低(n = 18,分别为p = 0.0395和p = 0.0109)。此外,与健康对照者(n = 17)相比,3级(G3)软组织肉瘤患者(n = 9)的膜联蛋白V阳性微泡总量以及白细胞(CD45阳性)和内皮来源(CD62E阳性)微泡显著更高(分别为p = 0.0304、p = 0.0254和p = 0.0357)。此外,与2级(G2)软组织肉瘤患者(n = 8)相比,G3软组织肉瘤患者(n = 9)的膜联蛋白V阳性和内皮来源(CD62E阳性)微泡水平更高(分别为p = 0.0483和p = 0.0045)。1级(G1)软组织肉瘤患者(n = 3)的血小板(CD61阳性)微泡水平显著低于G3软组织肉瘤患者(n = 9)(p = 0.0150)。在有VTE阳性病史的患者(n = 11)中,与无VTE病史的患者(n = 28)相比,发现活化血小板(CD62P - 和CD63阳性)微泡水平显著更高(分别为p = 0.0078和p = 0.0450)。
我们发现与G-2软组织肉瘤患者相比,G3软组织肉瘤患者外周血中循环的膜联蛋白V阳性和内皮来源(CD62E阳性)微泡水平显著更高。此外,我们表明高计数的活化血小板衍生微泡与VTE的发生相关。因此,检测这些微泡可能是早期诊断VTE风险增加的软组织肉瘤患者的一种有趣的新工具,可能通过更早使用血栓预防措施促进VTE预防。